laboratory data including liver function tests, serum tumor markers of alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II, and performance status. The MELD score was ...

Other blood tests and tumor marker tests revealed no significant ... Only a few cases were detected through elevated serum tumor markers, such as AFP (45.05%), CEA (5.68%), and CA19-9 (29.21%). In ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome. Circulating tumor DNA (ctDNA ...

In the last few years, much attention has been paid to this novel tumor marker that can be determined in EDTA-plasma and in the feces. It has been used in diagnosis and surveillance of a variety ...

Biological and therapeutic impact of tumor mutational burden in microsatellite instability/mismatch repair-deficient (MSI/dMMR) metastatic colorectal cancer (mCRC) treated with immune checkpoint ...

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) on December 5, 2024, Volume 16, Issue 22, titled "DNA-methylation age and ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome in a Cancer Research UK-funded study.

High levels of the cancer antigen 15-3 (CA 15-3) can indicate that breast cancer is present or has spread to other parts of the body. Among other things, the CA 15-3 blood test can reflect how ...

We discuss the challenges such as immunosuppressive microenvironment, tumor heterogeneity, and physical barriers that limit CAR-T efficacy. Emerging strategies, such as logic-gated and dual-targeting ...